Skip to search formSkip to main contentSkip to account menu

Myelodysplastic Syndrome, Unclassifiable

Known as: MDS-U, Unclassifiable MDS, Unclassifiable Myelodysplastic Syndrome 
A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category. There… 
National Institutes of Health

Related topics

Related topics

11 relations
AgranulocytosisBone MarrowBone marrow stem cellHematopoietic and Lymphoid Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cryobiopsy for Interstitial Lung Disease: The Heat Is On
Interstitial lung diseases (ILDs) are increasingly recognized as a heterogeneous group of lung disorders with a broad spectrum of… 
2019
2019
Late Breaking Abstract - Phase II trial of pirfenidone in patients with progressive fibrosing unclassifiable ILD (uILD)
Introduction: There are no approved therapies for patients with uILD, who may have irreversible ILD. We evaluated efficacy and… 
2017
2017
Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias
Objective Unclassifiable interstitial lung disease (ILD) is a common problem in clinical practice. These patients pose a distinct… 
Review
2015
Review
2015
A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Interstitial lung diseases (ILDs) form a heterogeneous group of rare diseases characterised by varying degrees of pulmonary… 
Review
2014
Review
2014
I Walk the Other Line: Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndromes
Patients with the myelodysplastic syndromes/myeloproliferative neoplasm (MDS/MPN) overlap, including chronic myelomonocytic… 
2013
2013
Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.
2012
2012
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML 
2009
2009
Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic…
2008
2008
Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS
Introduction: In MDS transfusional iron overload is known to be related to increased morbidity mainly due to cardiac and/or… 
2007
2007
[Vulvovaginitis. Occurrence and importance of mixed and unclassifiable pictures].
OBJECTIVE To evaluate the occurrence of mixed and unclassifiable vulvovaginitis (i.e. those, which fulfill the diagnostic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)